Your session is about to expire
← Back to Search
Casting vs Bracing for Scoliosis (CVBT Trial)
N/A
Recruiting
Led By Stuart L Weinstein, MD
Research Sponsored by University of Iowa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of idiopathic early-onset scoliosis
Child standing independently but not older than 3 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up on or before 24 months of treatment
Awards & highlights
No Placebo-Only Group
Summary
This trial compares casting and bracing for the treatment of scoliosis.
Who is the study for?
This trial is for children under 3 who can stand on their own and have been diagnosed with idiopathic early-onset scoliosis, showing a Cobb angle between 20° to 70°. A parent or guardian must consent to the child's participation. Children with conditions that don't meet these specific criteria are excluded.
What is being tested?
The study compares two methods of treating young children with scoliosis: one group will receive treatment through casting while another will use bracing. The goal is to see which method is more effective in managing this condition.
What are the potential side effects?
Possible side effects from casting or bracing may include skin irritation, discomfort, restricted movement, and potential impact on breathing due to pressure on the chest.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with scoliosis that started without a known cause when I was young.
Select...
My child can stand on their own and is under 3 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ on or before 24 months of treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~on or before 24 months of treatment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Curve Response
Secondary study objectives
Patient Health-related Quality of Life (HRQOL)
Other study objectives
Parent and Family Functioning
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: BracingActive Control1 Intervention
Subjects will be treated with full-time orthotics (braces)
Group II: CastingActive Control1 Intervention
Subjects will be treated with serial casting
Find a Location
Who is running the clinical trial?
University of IowaLead Sponsor
468 Previous Clinical Trials
893,051 Total Patients Enrolled
Orthopedic Research and Education FoundationOTHER
20 Previous Clinical Trials
5,230 Total Patients Enrolled
Pediatric Spine Study GroupUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Both children with scoliosis and one of their parents/guardians can participate in the study.This is not an exclusion criterion but rather a statement that a patient is eligible to participate in the clinical trial.This is not a complete criterion. Please provide more information.Your parents or legal guardians have given permission for you to take part in the study.I have been diagnosed with scoliosis that started without a known cause when I was young.The child's parent or legal guardian is responsible for their participation.You agree to take part in the study.My child can stand on their own and is under 3 years old.Your spine has a curve between 20 and 70 degrees.You have a spinal deformity where the angle between your ribs and spine is greater than 20 degrees or your ribs are in the second phase of development.
Research Study Groups:
This trial has the following groups:- Group 1: Bracing
- Group 2: Casting
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger